COMPARISON OF SAFETY AND IMMUNOGENICITY OF ADW AND AYW HEPATITIS B VACCINESPAPAEVANGELOU GJ; VISSOULIS CG; ROUMELIOTOU KARAYANNIS AJ et al.1982; J. MED. VIROL.; ISSN 0146-6615; USA; DA. 1982; VOL. 9; NO 3; PP. 231-236; BIBL. 11 REF.Article

SOURCE OF INFECTION DUE TO HEPATITIS B VIRUS IN GREECEPAPAEVANGELOU G; ROUMELIOTOU KARAYANNIS A; TASSOPOULOS N et al.1983; JOURNAL OF INFECTIOUS DISEASES; ISSN 0022-1899; USA; DA. 1983; VOL. 147; NO 6; PP. 987-989; BIBL. 15 REF.Article

Polyreactive IgM antibodies in the circulation are masked by antigen bindingSIGOUNAS, G; KOLAITIS, N; MONELL-TORRENS, E et al.Journal of clinical immunology. 1994, Vol 14, Num 6, pp 375-381, issn 0271-9142Article

Reduction of the dose of hepatitis B vaccinePAPAEVANGELOU, G; ROUMELIOTOU-KARAYANNIS, A; VISSOULIS, C et al.The Journal of infection. 1983, Vol 7, pp 69-70, issn 0163-4453, suppl. 1Article

Recurrent episodes of deep vein thrombosis in a young manGIOTOPOULOU, S; GIAFIS, K; DOKOU, E et al.International angiology. 2003, Vol 22, Num 2, pp 199-201, issn 0392-9590, 3 p.Article

Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern GreeceZALAVRAS, Ch. G; GIOTOPOULOU, S; DOKOU, E et al.International angiology. 2002, Vol 21, Num 3, pp 268-271, issn 0392-9590, 4 p.Article